Unusual sites of metastasis, such as peritoneal and chest wall, are increasingly reported in osteosarcoma patients after the use of new treatments.
May signal evolving metastatic patterns in osteosarcoma after gemcitabine-docetaxel; single case leaves open generalizability.
The authors report a case of peritoneal and chest wall metastases in a 17-year-old boy previously diagnosed of femur osteosarcoma with metastases in the lung and bones. Although the patient achieved complete remission after initial treatment, he presented with lung metastasis 15 months after initial diagnosis. They were resected 3 times and he received second-line chemotherapy with gemcitabine and docetaxel. However, 31 months after initial diagnosis he presented with abdominal and chest wall masses. In this report the authors discuss clinical outcomes and how unusual sites of metastasis are being increasingly reported after the use of new treatments.
No takes yet. Share an insight, caveat, or question.
Oñoro et al. (2011) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: